Russell Nofsinger
Vice President of Genomic Medicine @Fabric Genomics
Signup · Get unlimited contacts
WORK HISTORY
Vice President of Genomic Medicine @Fabric Genomics
San Diego, CA, US
Fabric Genomics has been the leading technology platform for NGS analysis, interpretation, and clinical reporting for hereditary disease for many years. Expansion of Fabric\'s genomic services to include end to end solutions for diagnostic sequencing have us poised to catalyze a (much needed) rapid expansion in access to testing for patients with undiagnosed disease. Integrating our world class, AI driven, analysis platform into a modular portfolio of clinical services, we collaborate with many of the leading laboratories, hospitals, and health centers across the US (and beyond) in support of rapid identification of genetic causes of disease using panels, WES, and WGS. In my current role, my goal is to expand access to genomically informed medicine through developing and expanding healthcare partnerships.
EDUCATION
UC San Diego
Ph.D., Biology
University of Illinois Urbana-Champaign
B.S., Cell and Structural Biology
SKILLS
ABOUT RUSSELL NOFSINGER
Business development leader driven by a deep commitment to improving patient outcomes through the advancement of and broader access to genomically informed medicine. My career has been dedicated to delivering cutting-edge biotech solutions, with a focus on transforming the landscape of clinical care through genomics. I have a proven track record of expanding access to advanced genomic diagnostics across new markets, helping to bring innovative molecular tools to clinicians and patients worldwide.At Rady Children\'s Institute for Genomic Medicine, my work in rapid Whole Genome Sequencing has contributed directly to saving the lives of acutely ill infants and children. Delivering timely molecular diagnoses empowers healthcare teams to make critical decisions that improve treatment and outcomes. Collaborating with a powerful network of Children\'s Hospitals, as well as payers, and health departments, I have helped to reshape how genomics is applied in clinical settings, ensuring that the most vulnerable patients benefit from these advancements. My time at WaferGen was similarly focused on expanding access to innovative genomic technologies. I led the development of partnerships that drove translational research and enabled the creation of molecular diagnostic tests that spanned a range of critical health conditions. I was particularly proud of fostering our clinical partnerships and leading our expansion into Asia, enabling access to groundbreaking diagnostics in new regions and supporting personalized medicine.I am passionate about continuing to drive the commercialization and integration of precision medicine tools that help clinicians make better, more informed decisions for their patients. Witnessing the impact of early diagnoses on patients and their families has led to an indelible desire to continue to expand access to genomically informed medicine. My overarching goal is to contribute to a future where genomic insights are available to all who need them—regardless of geography or financial limitations. Specialties:• Patient-Centered Business Development• Expanding Access to Genomic Medicine• Clinical Genomics• Precision/Personalized Medicine• Building and Leading Effective Teams• Commercial Leadership• Global Market Development• Technical Sales• Product Development & Launch• Next Generation Sequencing• Real-Time PCR
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.